Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiosteoporosis and Bone Protective Effect of Phyllanthin Against Glucocorticoid-induced Osteoporosis in Rats via Alteration of HO-1/Nrf2 and RANK/RANKL/OPG Pathway. | Dokl Biochem Biophys | 2025 | 39849266 | PubTator, text mining | PubMed |
| Bone regeneration: The influence of composite HA/TCP scaffolds and electrical stimulation on TGF/BMP and RANK/RANKL/OPG pathways. | Injury | 2025 | 39826405 | PubTator, text mining | PubMed |
| Mechanisms and structure-activity relationships of natural polysaccharides as potential anti-osteoporosis agents: A review. | Int J Biol Macromol | 2025 | 39814301 | PubTator, text mining | PubMed |
| Short bouts and long-term exercise reduce sedentary-induced bone loss and microstructural changes by modulating bone formation and resorption in healthy young male rats. | Sci Rep | 2025 | 39805876 | PubTator, text mining | PubMed |
| CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis. | J Cyst Fibros | 2025 | 39800643 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis on the Accuracy of Artificial Intelligence Algorithms in Individuals Gender Detection Using Orthopantomograms. | Int Dent J | 2025 | 39799063 | PubTator, text mining | PubMed |
| Transcription factor AP-2 Beta, a potential target of repetitive Transspinal magnetic stimulation in spinal cord injury treatment, reduced inflammation and alleviated spinal cord injury. | Exp Neurol | 2025 | 39798694 | PubTator, text mining | PubMed |
| Impact of short and long-term application of low-level laser therapy on mandibular alveolar process of osteoporotic rats - a Histological and Molecular Study. | Lasers Med Sci | 2025 | 39751945 | PubTator, text mining | PubMed |
| Insulin for oral bone tissue engineering: a review on innovations in targeted insulin-loaded nanocarrier scaffold. | J Drug Target | 2025 | 39707830 | PubTator, text mining | PubMed |
| Roles of osteoclasts in pathological conditions. | Pathol Int | 2025 | 39704061 | PubTator, text mining | PubMed |
| Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial. | Neuro Oncol | 2025 | 39700439 | PubTator, text mining | PubMed |
| Bone metastasis in endocrine-related cancer: unravelling invasion and destruction. | Endocr Relat Cancer | 2025 | 39699130 | PubTator, text mining | PubMed |
| Pyogenic spondylodiscitis from oral odontogenic origins: a frequently overlooked entity. | Spine J | 2025 | 39694447 | PubTator, text mining | PubMed |
| Perfluorooctane sulfonate (PFOS) induced bone loss by inhibiting FoxO1-mediated defense against oxidative stress in osteoblast. | Ecotoxicol Environ Saf | 2025 | 39675079 | PubTator, text mining | PubMed |
| Precocious Puberty in Children with Neurofibromatosis Type 1. | J Pediatr | 2025 | 39674537 | PubTator, text mining | PubMed |
| Deep Learning Architecture to Infer Kennedy Classification of Partially Edentulous Arches Using Object Detection Techniques and Piecewise Annotations. | Int Dent J | 2025 | 39645471 | PubTator, text mining | PubMed |
| Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report. | Endocr Metab Immune Disord Drug Targets | 2025 | 39639476 | PubTator, text mining | PubMed |
| Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease. | Circulation | 2025 | 39429140 | PubTator, text mining | PubMed |
| Effects of Stress on Biological Characteristics and Metabolism of Periodontal Ligament Stem Cells of Deciduous Teeth. | Int Dent J | 2025 | 39370340 | PubTator, text mining | PubMed |
| The two lives of the Mental Capacity Act: rethinking East-west binaries in comparative analysis. | Med Law Rev | 2025 | 39321426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=16